biotech news today obesity drugs glp-1 As an medicine physician, it is hard not to get excited about where the science is headed., This week, new phase 3 data on retatrutide showed average weight loss of over 28%, with some GLP-1 Agonists Weight Loss Drugs
Description
The depth and breadth of mechanistic insight continue to inspire new research directions and clinical applications, fueling enthusiasm for broader use and the realization of additional therapeutic benefits across diverse patient populations
Research & Innovation Disclosure STAAR LABS collaborates with clinics, pharmacies, and healthcare professionals to advance innovation in real-world metabolic health protocols
Copyright 2025 Nexstar Media, Inc
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging
Building healthy habits while on the medication sets you up for success later
When fibre is fermented by gut bacteria, it produces short-chain fatty acids, which have been shown to stimulate GLP-1 secretion in the gut
